The Right Formula for Acne: Importance of Vehicle Formulation in Tazarotene 0.045% Lotion Design, Application, Tolerability, and Efficacy
Open Access
- 1 January 2024
- journal article
- review article
- Published by Wiley in Dermatologic Therapy
- Vol. 2024 (1)
Abstract
The vehicles used for topical dermatological treatments can significantly contribute to treatment effects while also delivering ingredients to maintain skin barrier function and reduce irritation. Tazarotene 0.045% lotion was developed using proprietary polymeric emulsion technology to provide uniform and efficient delivery of the active ingredient as well as improved safety and tolerability compared to higher‐dose tazarotene formulations. The lotion vehicle additionally provides rapid and sustained improvements in moisturization and skin barrier function with patient‐friendly application and cosmetic properties. Compared with trifarotene 0.005% cream, tazarotene 0.045% lotion demonstrated ∼30% greater spreadability and a lower potential for irritation. In clinical trials and investigator‐initiated studies, tazarotene 0.045% lotion demonstrated efficacy in the treatment of facial and truncal acne and improved skin oiliness. Facial acne improvements were similar among study participants grouped by sex, race, ethnicity, or age. In a head‐to‐head study, efficacy was comparable to tazarotene 0.1% cream with approximately half the rate of treatment‐emergent adverse events. Tazarotene 0.045% lotion is a beneficial acne treatment option for patients of varying ages, races, ethnicities, and skin types, delivered in a formulation that can be easily used on the face, back, and chest.Keywords
Funding Information
- Ortho Dermatologics
This publication has 36 references indexed in Scilit:
- Guidelines of care for the management of acne vulgarisJournal of the American Academy of Dermatology, 2024
- Bringing hydrogel-based craniofacial therapies to the clinicActa Biomaterialia, 2021
- 50 Years of Topical Retinoids for Acne: Evolution of TreatmentAmerican Journal of Clinical Dermatology, 2021
- Real-world adherence to topical therapies in patients with moderate acneJAAD International, 2021
- Vehicles for atopic dermatitis therapies: more than just a placeboJournal of Dermatological Treatment, 2020
- Psoriasis patient preferences for topical drugs: a systematic reviewJournal of Dermatological Treatment, 2019
- Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technologyJournal of Dermatological Treatment, 2019
- Topical Retinoids in Acne Vulgaris: A Systematic ReviewAmerican Journal of Clinical Dermatology, 2019
- Why Topical Retinoids Are Mainstay of Therapy for AcneDermatology and Therapy, 2017
- The critical role of the vehicle to therapeutic efficacy and patient complianceJournal of the American Academy of Dermatology, 1998